論文 2023年
論文バックナンバー
2023年
英文
- Yamairi K, Niki M, Imoto W, Kuwabara G, Shibata W, Oshima K, Yamada K, Kaneko Y, Kakeya H. Two cases of Clostridium ramosum bacteremia with intestinal perforation: the antimicrobial susceptibility of clinical strains. Anaerobe, 2023 Jan12;80:102695. doi: 10.1016/j.anaerobe.2023.102695.
- Kobayashi M, Miyamoto A, Watanabe T, Sawa K, Sato K, Yamada K, Yoshii N, Yamada K, Kawamoto K, Uji M, Shiraishi S, Asai K, Kakeya H, Kawaguchi T. COVID-19 vaccination benefits in preventing severe disease in mild-to-moderate cases: an analysis in the first specialized hospital for COVID-19 in Japan. Resp Invest, 2023;61:230-239.
- Ogawa M, Niki M, Imoto W, Dobashi A, Imai M, Takayama N, Mitani K, Kakuno S, Shibata W, Yamada K, Kakeya H. Characterization of Aspergillus spp. isolated from patients with coronavirus diseases 2019. J Infect Chemother 2023, Accepted
- Nakaya Y, Nakashima Y, Harada N, Yamada K, Makuuchi Y, Kuno M, Takakuwa T, Okamura H, Nanno S, Nishimoto M, Koh H, Nakagama Y, Kido Y, Kanno T, Suzuki T, Nakamae H, Kakeya H, Hino M. Successful treatment of proven coronavirus disease 2019-associated pulmonary aspergillosis with liposomal amphotericin B in a patient with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2023;29:223-227. doi: 10.1016/j.jiac.2022.10.020.
- Thoda M, Oinuma KI, Sakiyama A, Tsubouchi T, Niki M, Namikawa H, Yamane K, Yamada K, Watanabe T, Asai K, Kakeya H, Kaneko Y, Kawaguchi T. Rifampicin exerts anti-mucoviscous activity against hypervirulent Klebsiella pneumoniae via the binding to RNA polymerase β subunit. J Glob Antimicrob Resist. 2023;32:21-28. doi: 10.1016/j.jgar.2022.11.018.
和文
- 掛屋 弘, 河野 茂. 感染症の臨床症状と診断. 井村裕夫編 第５版 わかりやすい内科学. 文光堂, 東京, 2023. pp 367-372
- 掛屋 弘. ウイルス性出血熱. 今日の治療指針2023. 医学書院 2023, pp170-172.
- 仁木 誠, 井本和紀, 山田康一, 金子幸弘, 掛屋 弘. 血液培養から検出されたClostridium属およびClostridioides属の細菌学的検討. 日本嫌気性菌学会雑誌 2023;52(2):66-77.
